DERIANO Ludovic : Institut Pasteur : Lymphocyte Development and Oncogensis Lab

Unit : Departement d'Immunologie - Institut Pasteur

Institut Pasteur
Immunology Department
Metchnikoff building
25, rue du Docteur Roux
75015 PARIS

Speciality : Department DGNRV

Director of the unit : Matthew ALBERT

Principal investigator :

Email : Phone number: +33 (0)1 44 38 93 55

Composition of research team :

  • DERIANO Ludovic (CR-IP)

5 Recent publications of the research team :

L. Deriano and D.B. Roth. Modernizing the Nonhomologous End Joining Repertoire: Alternative and Classical NHEJ Share The Stage. Annual Review of Genetics. 2013 Nov 23;47:433-55.

M. Mijušković, S.M. Brown, Z. Tang, C.R. Lindsay, E. Efstathiadis, L. Deriano, D.B. Roth. A streamlined method for detecting structural variants in cancer genomes by short read paired-end sequencing. PLoS One. 2012 Oct 29; 7(10):e48314.

L. Deriano, J. Chaumeil, M. Coussens, A. Multani, Y. Chou, A.V. Alekseyenko, S. Chang, J.A. Skok, D.B. Roth. The RAG2 C-terminus suppresses genomic instability and lymphomagenesis. Nature. 2011 Mar 3; 471(7336): 119-2.

L. Deriano, T.H. Stracker, A. Baker, J.H.J. Petrini, D.B. Roth. Roles for NBS1 in alternative end joining of V(D)J recombination intermediates. Mol Cell. 2009 Apr 10; 34(1): 13-25.

B. Corneo*, R.L. Wendland*, L. Deriano*, X. Cui, I.A. Klein, S. Wong, S. Arnal, A.J. Holub, G.R. Weller, B.A. Pancake, S. Shah, V.L. Brandt, K. Meek, D.B. Roth. RAG mutations reveal robust alternative end joining. Nature, 2007 Sep; 449(7161): 483-6. (*Equal contribution)